Pataday and Coreg drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pataday (olopatadine hydrochloride) and Coreg (carvedilol). Common drug interactions include fall among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Pataday and Coreg. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.

What is Coreg?

Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 49,583 Coreg users. Check the latest studies of Coreg.

On Jul, 27, 2026

37 people who take Pataday and Coreg together, and have interactions are studied.

What are the common drug interactions of Pataday and Coreg, by gender? *:

female:

Fall
Weight decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Ear infection
Eye infection
Fatigue (feeling of tiredness)
Foot fracture
Headache (pain in head)
Limb injury
Peripheral swelling

male:

Chronic kidney disease
Abdominal discomfort
Impaired healing
Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
Nephropathy (damage to or disease of a kidney)
Pemphigoid (tense blisters on the skin)
Rash
Secretion discharge
Skin ulcer
Weight decreased

What are the common drug interactions of Pataday and Coreg, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)
Abdominal discomfort
Asthma
Cough
Fluid retention (an abnormal accumulation of fluid in the blood)
Nephrogenic anaemia (anaemia due to kidney disease)
Nephropathy (damage to or disease of a kidney)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Therapeutic response unexpected

60+:

Weight decreased
Anaemia (lack of blood)
Nausea (feeling of having an urge to vomit)
Vertigo
Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Chronic kidney disease
Haemoglobin decreased
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

Diabetes: 6 people, 16.22%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 16.22%
Immunodeficiency Common Variable: 5 people, 13.51%
High Blood Cholesterol: 5 people, 13.51%
Asthma: 4 people, 10.81%
Pain: 4 people, 10.81%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 10.81%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 8.11%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 8.11%
Blood Pressure Abnormal: 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Pataday and Coreg?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously